---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-127038"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:29:55.777892+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences regains Nasdaq compliance as stock price holds above $1.00

## Summary
- Received Nasdaq Staff letter on Nov 13, 2024 confirming regained compliance.
- Closing bid price was $1.00 or greater for 10 consecutive business days through Nov 13.
- Now compliant with Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.
- Resolves prior deficiency; no further action required from the company.

## SEC filing metadata
- accession: 0000950170-24-127038
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000095017024127038/0000950170-24-127038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000095017024127038/kzr-20241113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-127038
- JSON: https://secwatch.observer/filing/0000950170-24-127038.json
- Plain text: https://secwatch.observer/filing/0000950170-24-127038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.